Fatty Liver, NAFLD & NASH
Will the reformulation of 2,4 Dinitrophenol evolve into a turning point in the global battle against a fatty liver?
It is important to drink plenty of fluids in the summer to stay hydrated. Learn about the best beverage choices you can make for your liver’s well being.
Signs of liver disease can be vague. Do you suffer from any of these signs of a bad liver?
Intercept Pharmaceuticals announced it will be conducting a Phase 3 trial on obeticholic acid (OCA) for the treatment of patients with non-cirrhotic NASH with liver fibrosis.
Learn about aramchol, an up and coming drug to treat advanced stage fatty liver disease.
Recommended treatments for alcoholic hepatitis fail to keep patients alive.
â€œIt’s predicted that by the end of this decade, non-alcoholic fatty liver disease will be be the most common underlying reason why people are required to have liver transplants, overtaking alcohol.â€
An experimental drug for non-alcoholic fatty liver disease has received high marks in a mid-stage trial.
A common probiotic has been shown to minimize lipogenesis and promote lipolysis – complementary actions that both prevent and reverse fat from accumulating in the liver.
Providing the gastrointestinal system with beneficial bacteria could be part of a winning strategy to defeat nonalcoholic fatty liver disease.
Besides giving you a headache and heart palpitations, MSG (monosodium glutamate) might be contributing to obesity and a fatty, inflamed liver.
Eating a lot of sugar can accelerate fat accumulation in the liver and initiate metabolic syndrome, but a new study may have found a way around this dilemma.
Is it true that your race might determine where you store fat and, thus, may make you more or less vulnerable to fatty liver disease?
When conceptions about liver disease stray far from the truth, efforts to prevent, detect and treat are hampered.
Likely a consequence of small intestine bacterial overgrowth, many people with chronic liver disease may have difficulty digesting dairy.
Understanding the plea for insurance coverage of lap-band surgery to prevent liver cancer reiterates why stopping fatty liver disease is imperative.
Hone your awareness of liver scar progression, the importance of stopping its advancement and seven strategies to accomplish this goal.
A new drug (a selective synthetic LXR inverse agonist) developed by Scripps scientists could change the way we approach fatty liver disease.